“Budget impact analysis resulting from the use of dabigatran etexilate in preventing stroke in patients with non-valvular atrial fibrillation in Italy” (2012) Farmeconomia. Health Economics and Therapeutic Pathways, 13(3), pp. 121–131. doi:10.7175/fe.v13i3.268.